Novartis CEO says pharma giant has the firepower for big M&A deals: 'Can never be done'
3 Articles
3 Articles
Novartis Eyes Big M&A - PressReach
Novartis, the Swiss pharmaceutical giant, is expressing optimism about its future growth opportunities through major mergers and acquisitions (M&A). The company’s CEO, Vas Narasimhan, recently highlighted the organization’s strategic position to capitalize on substantial M&A deals, a move that aligns with its long-term growth objectives. Novartis (NYSE:NVS) has consistently demonstrated robust financial health, which provides it with the necessa…
Novartis CEO says pharma giant has the firepower for big M&A deals: ‘Can never be done’ – DG Verifications & Stats
This photograph taken on October 30, 2022, shows the logo of the Swiss pharmaceutical and drug maker Novartis on a building in Basel. Gabriel Monnet | Afp | Getty Images Novartis “can never be done” when it comes to major acquisitions in its sector as it always needs to look for the next “great asset,” CEO Vas Narasimhan told CNBC. In order to offset the hit from generics competition Novartis has been on a buying spree, acquiring more than 35 co…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
 US Edition
US Edition









